Users Stopping Weight-Loss Jabs Gain Back Weight Four Times Faster Than Those on Conventional Diets

Illustration of pharmaceutical injection and weighing machine
Weight management involves ongoing approaches.

New research suggests that people who come off new slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass at a significantly accelerated pace than those who stop traditional diet and exercise plans.

Published data in a major health publication points out that while overweight individuals frequently drop substantial amounts of their total mass while undergoing treatment, the weight returns at an estimated rate of nearly a kilo each month upon discontinuation.

"Users buying these treatments should be aware of the risk of fast rebound weight gain when the therapy concludes," stated researcher Dr. Susan Jebb.

Such speed of recovery suggests a reversion to starting weight in about 18 months.

Weighing Therapies

The research, which looked at dozens of studies involving over 9,000 of patients, contrasted the outcomes of the injectable medications with other pills.

Scientists note that individuals who shed pounds through dieting generally experience a slower creep back—perhaps 100 grams monthly—post-intervention.

Understanding the Rapid Regain

Doctors believe the mode of action of the jabs explains the heightened rebound.

The injections imitate a body's own chemical called GLP-1, which moderates hunger.

"Sustained high doses of the hormone levels several times higher than the body's typical production could lead to the system to produce less of its endogenous hormone, and could lessen sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this hormone supplement leads to appetite is uncontrolled, making overeating far more likely."

An Ongoing Issue?

The NHS suggest the jabs for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

A number of clinicians say that, considering the high risk of relapse, the therapy is often life-long.

This opinion is reinforced by pharmaceutical companies, who state that the findings "highlight the persistent character of excess weight," akin to managing diseases like hypertension.

Patient Experiences

People who have discontinued the medication describe a sudden resurgence of appetite.

"It felt as if something activating and you're instantly extremely hungry," described one woman.

This difficulty is worsened if users have not developed lasting lifestyle or habit modifications during treatment.

Growing Interest

Figures show that millions of adults in the UK have tried these injections in the last 12 months, with demand continuing to grow.

  • Use is greater among women than males.
  • The middle-aged demographic shows the highest level of interest.
  • Many obtain the drugs through private healthcare rather than the NHS.

In conclusion, researchers caution that while the jabs are powerful tools for shedding pounds, they are not a standalone cure and lasting health benefits likely depends on combined lifestyle management.

Charles Ortiz
Charles Ortiz

A tech journalist and digital strategist with over a decade of experience covering emerging technologies and their impact on society.